Skip to main content
Premium Trial:

Request an Annual Quote

The Next Stage

The Boston-based Partners HealthCare System plans to implement whole-genome sequencing and interpretation of that data for its hospitals next month, The Boston Globe reports. Its nine hospitals include Massachusetts General Hospital and Brigham and Women's Hospital. The Globe adds that the service is expected to cost about $9,000.

Prior to launching the service, the hospital system has partnered with Illumina to include its GeneInsight software, which was developed in part to help with data interpretation, with Illumina's MiSeq machine. Currently, the Globe adds, that software-machine combo is being used in a few pilot projects for targeted gene testing.

"As an academic medical center, we can differentiate ourselves around interpreting genetic data," says Trung Do, executive director of business development at Partners.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.